Showing 1 - 10 of 86
Case review 2020-07-13
Product liability and the CPA: failure to consider product risks and benefits is all risk and no benefit
On 3 July 2020, Lambert J handed down judgment in the long standing Seroxat group litigation, Bailey and others v GlaxoSmithKline.
As smart devices become more and more integral to our personal day to day lives, the cyber-security risks to our data and privacy are also becoming more personal.
The results of Part 2 of the Law Commissions’ joint consultation into the regulation of automated vehicles, “emphasised how uncertain the future has become, and how regulation must be sufficiently flexible to deal with a wide variety of eventualities.”
Whatever the jurisdiction, companies should be adequately prepared to initiate a robust product recall.
On 13 February 2020, the Food Standards Agency (FSA) published guidance on the regulation of products for consumption containing cannabidiol (CBD).
Case review 2020-05-04
In a reminder of the scrutiny to which the courts will use when reviewing costs budgets, the High Court has rejected an application by group litigation claimants to retrospectively revise a previously approved costs budget and reduced a future budget by more than half.
Financial Conduct Authority has announced it intends to ask the courts to rule on whether a ‘representative sample of the most frequently used’ BI policy wording provide cover for COVID-19 related losses.
With the UK Government calling on organisations from a variety of industries to help solve the country’s COVID-19 ventilator shortage, we explore what organisations should consider when considering manufacturing ventilators.
Case review 2020-02-18
On 6 February 2020, the Advocate General’s Opinion in RB v TÜV Rheinland LGA Products and Allianz IARD was announced. The Advocate General opined that Article 18 of the TFEU does not preclude an insurance clause limiting cover to harm caused in the territory where the policy was issued.